Signa is the Latin word for symptom - a sign. In Signa, symptoms can be monitored by recording side effects, answering questionnaires, and performing tests that are recorded and saved as videos.

Signa was primarily developed for use in a research project that examines two medical treatments in patients with myotonia.

It is only possible to open Signe after handing over the user ID and code from the research study staff.

Signa has been developed in a collaboration between doctor Grete Andersen, clinic for nerve and muscle diseases at Rigshospitalet, the capital region and ZiteLab ApS.